跳至主要内容
临床试验/NCT04427904
NCT04427904招募中2 期

Bupivacaine Versus Lidocaine Infiltration for Postoperative Pain in Thyroid Surgery: A Randomized Controlled Trial

St. Joseph's Healthcare Hamilton2 个研究点 分布在 1 个国家目标入组 210 人开始时间: 2022年6月1日最近更新:
适应症
相关药物

试验速览

阶段
2 期
状态
招募中
入组人数
210
试验地点
2
主要终点
Postoperative Pain

研究概览

简要总结

The purpose of this study is to compare the efficacy of Bupivicaine and Lidocaine for postoperative pain control in thyroid surgery.

详细描述

Patients planned for total thyroidectomy will be recruited for participation. After being informed about the study and potential risks, all patients giving written informed consent will be screened for eligibility for study entry. Patients that meet inclusion and exclusion criteria will be randomized via block randomization in a double blind fashion and a 1:1 ratio to surgical incision infiltration with Bupivacaine (0.5% with 1:200 000 epinephrine) or Lidocaine (2% with 1:100 000 epinephrine).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of thyroid disease (malignant tumors T1-T3/NX-N1a, benign tumors)
  • Planned for thyroid surgery with midline neck incision (total thyroidectomy, completion thyroidectomy, with or without central neck dissection)
  • Will be admitted for at least 12h postoperatively

排除标准

  • Thyroid cancer staged as T4 (invasion, anaplastic) or requiring sternotomy
  • Thyroid cancer staged as N1b (cervical, retropharyngeal, superior mediastinal nodal involvement)
  • Previous ipsilateral thyroid surgery to operation side
  • Previous total thyroidectomy or completion thyroidectomy
  • History of neck radiation therapy
  • Neck dissection beyond central neck (levels 1-5)
  • Goiter extending beyond sternal notch (intrathoracic) or requiring sternotomy
  • Surgery requiring extension of incision beyond 8 cm
  • History of diabetes mellitus
  • History of renal or liver disease
  • History of narcotic abuse
  • History of chronic pain medications use in past 6 months for any condition
  • History of coagulation defect
  • Allergy to Bupivacaine or Lidocaine

结局指标

主要结局

Postoperative Pain

时间窗: 12 hours after surgery

Patient reported postoperative pain reported on a 10cm pain visual analogue scale (VAS), minimum value of 0cm (no pain) and maximum value of 10cm (worst pain possible), lower VAS measurement represents better outcome

次要结局

  • First dose of additional postoperative analgesia(Up to 72 hours after surgery)
  • Inpatient analgesia utilization(Up to 72 hours after surgery)
  • Outpatient analgesia utilization(Up to 4 weeks after surgery)
  • Time to return of sensation(Up to 4 weeks after surgery)
  • Incidence of postoperative complications(4 weeks)
  • Incidence of local anesthesia related adverse events(4 weeks)
  • Postoperative pain(4 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Michael Xie

Resident Physician

St. Joseph's Healthcare Hamilton

研究点 (2)

Loading locations...

相似试验